PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

计划入组 70 人 · 首次发布于 2022 年 3 月 18 日

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

计划入组 28 人 · 首次发布于 2019 年 8 月 28 日

The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer

计划入组 96 人 · 首次发布于 2025 年 9 月 8 日

anti-EX02 autologous CAR T-cell therapy (pancreatic cancer/bile duct cancer)

Ox bile extract

Artificial Bear Bile Powder

OncoSil Medical Ltd

CENTER WEST CANCER

United States

Fujian Cancer Hospital (Fujian Cancer Institute, Fujian Cancer Prevention and Treatment Center)

China

PLT012 Receives FDA Orphan Drug Designation for Liver and Bile Duct Cancers

FDA Grants Orphan Drug Designation to Pilatus Biosciences' PLT012 for Liver and Bile Duct Cancer

Coherus' Casdozokitug Shows Promising Results in Liver Cancer Phase 2 Trial